Microglia in depression: current perspectives
Xiaoning Jia1,2, Zhihua Gao3,4,5, Hailan Hu6,7,8,9,10,11
1Department of Psychiatry of First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Abstract:
Major depressive disorder (MDD) is a prevalent psychiatric disease that involves malfunctions of different cell types in the brain. Accumulating studies started to reveal that microglia, the primary resident immune cells, play an important role in the development and progression of depression. Microglia respond to stress-triggered neuroinflammation, and through the release of proinflammatory cytokines and their metabolic products, microglia may modulate the function of neurons and astrocytes to regulate depression. In this review, we focused on the role of microglia in the etiology of depression. We discussed the dynamic states of microglia; the correlative and causal evidence of microglial abnormalities in depression; possible mechanisms of how microglia sense depression-related stress and modulate depression state; and how antidepressive therapies affect microglia. Understanding the role of microglia in depression may shed light on developing new treatment strategies to fight against this devastating mental illness.
Insights
Microglia, the brain's immune cells, are increasingly linked to major depressive disorder (MDD). This review explores how microglia dysfunction contributes to depression and may offer new therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Major depressive disorder (MDD) is a widespread brain disorder affecting multiple cell types.
- Microglia, the central nervous system's resident immune cells, are implicated in MDD's development and progression.
- Stress-induced neuroinflammation involves microglia, influencing neuronal and astrocyte function.
Purpose of the Study:
- To review the critical role of microglia in the etiology of depression.
- To explore the dynamic states and abnormalities of microglia in depression.
- To examine mechanisms linking microglia to depression and the impact of antidepressant therapies.
Main Methods:
- Literature review focusing on microglia's role in depression.
- Analysis of correlative and causal evidence for microglial involvement.
- Discussion of stress sensing and modulation mechanisms by microglia.
Main Results:
- Microglial abnormalities are increasingly evident in depression.
- Microglia can modulate neuronal and astrocyte function via inflammatory mediators.
- Antidepressant therapies may influence microglial activity.
Conclusions:
- Microglia are key players in the pathophysiology of depression.
- Understanding microglial roles offers potential for novel depression treatments.
- Targeting microglia may provide new therapeutic strategies for MDD.
More Related Videos
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...


